ArticlePharmacoEconomics - open2026

Budget Impact of Prophylactic Letermovir to Prevent Cytomegalovirus Disease in High-Risk Adult Kidney Transplant Recipients.

Murvin Jootun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.